Nospharma
Biotechnology Research
Montreal, Quebec, Ca
3 employees
- Employees
- 3
- Contacts
- 1
- Emails
- 1
- Phones
- 1
Nospharma Overview
- Headquarters
- Montreal, Quebec, Ca
- Website
- www.nospharma.ca
- Industry
- Biotechnology Research
- Employees
- 3
- Founded
- 2022
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
About Nospharma
Nospharma is a preclinical therapeutics company developing innovative treatments for rare genetic neurodevelopmental disorders, including Fragile X Syndrome, SynGAP1 Syndrome, and GRIN Disorder. Our technology comes from research originally conducted at the Bowie Lab at McGill University. We aim to deliver novel and effective therapeutics as quickly as possible to make a lasting difference in the lives of millions of patients and their caring families.
Nospharma Contact Details
- People in AeroLeads
- 2
- With contact data
- 1
- Email contacts
- 1
- 50.0% coverage
- Phone contacts
- 1
- 50.0% coverage
Nospharma Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Derek Bowie | Full Professor, Neuroscientist at Mcgill University and Co-founder/chief Scientific Officer of Nospharma |
View
|
|
| David Baker | Life Sciences Executive I Board Director I Mentor I Advisor | Philadelphia, Pennsylvania, United States |
Email
Phone
|
Compare Similar Companies to Nospharma
District 3 Innovation
Professional Training And Coaching
Congruence Therapeutics
Biotechnology Research
BIOQuebec
Industry Associations
Inversago Pharma
Biotechnology Research
Modulari-T Bio
Biotechnology Research
Laurent Pharmaceuticals
Biotechnology Research
Kli Capital
Investment Management
Giiant Pharma Inc.
Biotechnology Research
Cura Therapeutics Inc.
Biotechnology Research
LyfGen
It Services And It Consulting